Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 19/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.72 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.58 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30882126 | 0.91 | HDAC4 (0.69) | HDAC4HDAC6HDAC1HDAC8HDAC5 | |
| SCHEMBL21581671 | 0.87 | HDAC4 (0.72) | HDAC4HDAC6HDAC1HDAC8HDAC5 | |
| SCHEMBL20640857 | 0.87 | HDAC4 (0.76) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL17074132 | 0.86 | HDAC4 (0.74) | HDAC4HDAC6HDAC1HDAC8HDAC5 | |
| SCHEMBL14645419 | 0.85 | HDAC4 (1.00) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL20640861 | 0.85 | HDAC4 (0.69) | HDAC4HDAC6HDAC1HDAC8HDAC5 | |
| SCHEMBL14645446 | 0.84 | HDAC4 (1.00) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL14645766 | 0.84 | HDAC4 (0.75) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL21462822 | 0.84 | HDAC4 (0.55) | HDAC4HDAC6HDAC1HDAC8HDAC3 | |
| SCHEMBL14935021 | 0.82 | HDAC4 (0.72) | HDAC4HDAC6HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606548-B2 | Fungicidal oxadiazoles | FMC CORPORATION (US) | 2026-04-21 | — | — | US | disclosed |
| US-20240166638-A1 | FUNGICIDAL OXADIAZOLES | FMC CORP (US) | 2024-05-23 | — | — | US | disclosed |
| CN-118047729-A | Fungicidal oxadiazoles | FMC公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-118047771-A | Fungicidal oxadiazoles | FMC公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-4361150-A2 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | FMC Corporation (US) | 2024-05-01 | — | — | EP | disclosed |
| EP-3660007-B1 | OXADIAZOLE COMPOUND AND FUNGICIDE FOR AGRICULTURAL AND HORTICULTURAL USE | NIPPON SODA CO (JP) | 2024-04-10 | — | — | EP | disclosed |
| CN-112004813-B | Oxadiazole compounds for controlling phytopathogenic fungi | PI工业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20240090503-A1 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | FMC CORPORATION | 2024-03-21 | — | — | US | disclosed |
| CN-110650956-B | Fungicidal oxadiazoles | FMC公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-4262396-A1 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | FMC CORPORATION (US) | 2023-10-25 | — | — | EP | disclosed |
| WO-2017198852-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-11-23 | — | — | WO | disclosed |
| WO-2017157962-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-21 | — | — | WO | disclosed |
| WO-2017157962-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-21 | — | — | WO | disclosed |
| EP-2729454-B1 | NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG (CH) | 2015-09-16 | — | — | EP | disclosed |
| US-9056843-B2 | Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease | NOVARTIS AG (CH) | 2015-06-16 | — | — | US | disclosed |
| US-20140142105-A1 | NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG (CH) | 2014-05-22 | — | — | US | disclosed |
| EP-2729454-A1 | NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | Novartis AG (CH) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013066835-A2 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013066835-A2 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013008162-A1 | NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG (CH) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166638-A1 | FUNGICIDAL OXADIAZOLES | OXA1L, NOX1, TH | HDAC4 3224/4885HDAC6 1038/4885HDAC1 1586/4885 |
| US-20140142105-A1 | NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | HDAC4, HDAC5, HDAC6 | HDAC4 1/4885HDAC6 3/4885HDAC1 5/4885 |
| US-12606548-B2 | Fungicidal oxadiazoles | AOC2, AOC3, MT-CO3 | HDAC4 3050/4885HDAC6 1102/4885HDAC1 2753/4885 |
| US-20240090503-A1 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | NOX1, TH, NOX3 | HDAC4 2535/4885HDAC6 487/4885HDAC1 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.